Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Economic considerations and formulary management of oral antipsychotics
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Economic considerations and formulary management of oral antipsychotics'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Adverse Effects
12%
Agranulocytosis
25%
Antipsychotics
25%
Atypical Antipsychotics
12%
Blood Count
12%
Clinical Efficacy
12%
Clozapine
100%
Direct Costs
12%
Economic Considerations
100%
Extrapyramidal Symptoms
12%
Formulary Management
100%
Health Care Costs
12%
Health Systems
12%
Healthcare Environment
12%
Healthcare Expenditure
12%
Hospitalization Days
12%
Indirect Costs
12%
Managed Care Organization
12%
Negative Symptoms
12%
Negative Symptoms of Schizophrenia
12%
Novel Agents
12%
Novel Antipsychotics
25%
Olanzapine
12%
Oral Antipsychotics
100%
Patients with Schizophrenia
25%
Pharmacoeconomic Analysis
12%
Pharmacoeconomics
12%
Quetiapine
12%
Restricted Use
12%
Risperidone
50%
Schizophrenia
37%
Second-generation Antipsychotics
12%
Treatment-resistant Patients
12%
Typical Antipsychotics
25%
U.S. Food
12%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
12%
Agranulocytosis
25%
Antipsychotic
25%
Atypical Antipsychotics
12%
Clozapine
100%
Extrapyramidal Symptoms
12%
Negative Syndrome
25%
Olanzapine
12%
Pharmacoeconomics
25%
Quetiapine
12%
Retrospective Study
12%
Risperidone
50%
Typical Antipsychotic
100%